Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: J Pediatr. 2015 May 9;167(2):344–352.e1. doi: 10.1016/j.jpeds.2015.04.032

Table 2.

Adjusted HRs for younger age at menarche for incident type 2 diabetes, impaired fasting glucose, and metabolic syndrome: The CARDIA Study

Age at Menarche
8–11 yrs 12–13 yrs 14–17 yrs Continuous (per yr younger)
HR
(95% CI)
HR
(95% CI)
HR
(95% CI)
HR
(95% CI)
p-race
interaction
All Women
Type 2 Diabetes N=69 N=159 N=43 N=271
  Model 1 1.69 (1.16, 2.29) 1.38 (0.99, 1.94) REF 1.10 (1.02, 1.17) 0.20
  Model 2 1.61 (1.09, 2.37) 1.35 (0.96, 1.89) REF 1.08 (1.00, 1.16) 0.31
  Model 3 1.33 (0.90, 1.96) 1.24 (0.88, 1.75) REF 1.04 (0.95, 1.12) 0.37
IFG N=146 N=355 N=112 N=613
  Model 1 1.49 (1.16, 1.91) 1.29 (1.05, 1.60) REF 1.11 (1.07, 1.16) 0.08
  Model 2 1.50 (1.17, 1.94) 1.31 (1.06, 1.62) REF 1.11 (1.06, 1.16) 1.17
  Model 3 1.28 (0.99, 1.62) 1.22 (0.98, 1.51) REF 1.08 (1.02, 1.13) 0.05
MetS N=158 N=368 N=103 N=629
  Model 1 1.96 (1.54, 2.48) 1.50 (1.22, 1.85) REF 1.15 (1.10, 1.20) 0.0002
  Model 2 1.95 (1.53, 2.47) 1.49 (1.20, 1.84) REF 1.15 (1.10, 1.19) 0.0005
  Model 3 1.45 (1.14, 1.85) 1.31 (1.06, 1.62) REF 1.09 (1.04, 1.14) <.0001
African-American Women
Type 2 Diabetes N=48 N=114 N=31 N=193
  Model 1 1.50 (0.96, 2.36) 1.33 (0.90, 1.98) REF 1.07 (0.97, 1.15)
  Model 2 1.47 (0.93, 2.33) 1.29 (0.87, 1.93) REF 1.06 (0.96, 1.15)
  Model 3 1.28 (0.80, 2.04) 1.28 (0.86, 1.92) REF 1.03 (0.92, 1.12)
IFG N=96 N=182 N=70 N=348
  Model 1 1.30 (0.96, 1.77) 1.03 (0.78, 1.35) REF 1.08 (1.01, 1.14)
  Model 2 1.29 (0.94, 1.77) 1.02 (0.77, 1.34) REF 1.07 (1.01, 1.14)
  Model 3 1.12 (0.81, 1.54) 0.97 (0.73, 1.28) REF 1.04 (0.97, 1.11)
MetS N=101 N=212 N=75 N=388
  Model 1 1.58 (1.18, 2.09) 1.23 (0.95, 1.58) REF 1.09 (1.03, 1.14)
  Model 2 1.55 (1.17, 2.08) 1.20 (0.93, 1.55) REF 1.09 (1.03, 1.15)
  Model 3 1.17 (0.87, 1.57) 1.07 (0.83, 1.38) REF 1.03 (0.97, 1.09)
White women
Type 2 Diabetes N=21 N=45 N=12 N=78
  Model 1 2.31 (1.13, 4.71) 1.48 (0.78, 2.81) REF 1.17 (1.03, 1.29)
  Model 2 1.98 (0.96, 4.13) 1.41 (0.74, 2.70) REF 1.12 (0.97, 1.24)
  Model 3 1.14 (0.53, 2.46) 1.00 (0.51, 1.96) REF 1.00 (0.82, 1.15)
IFG N=50 N=173 N=42 N=265
  Model 1 1.79 (1.18, 2.69) 1.75 (1.25, 2.46) REF 1.16 (1.09, 1.23)
  Model 2 1.84 (1.21, 2.80) 1.89 (1.21, 2.66) REF 1.16 (1.08, 1.23)
  Model 3 1.52 (0.99, 2.33) 1.63 (1.16, 2.31) REF 1.13 (1.04, 1.20)
MetS N=57 N=156 N=28 N=241
  Model 1 3.04 (1.97, 4.69) 2.26 (1.53, 3.32) REF 1.26 (1.19, 1.32)
  Model 2 3.04 (1.96, 4.72) 2.35 (1.59, 3.46) REF 1.25 (1.18, 1.32)
  Model 3 2.15 (1.36, 3.39) 2.02 (1.37, 2.98) REF 1.19 (1.11, 1.26)

Notes:

Model 1 = age, center, and race adjusted.

Model 2 = Model 1+parental history of diabetes (Y/N), educational status (<HS, HS, >HS), pre-high school physical activity, high school physical activity, smoking status (current, former, never), oral contraceptive use (yes/no), physical activity level (METS), and alcohol intake (g/day).

Model 3 = Model 2+baseline BMI.

Diabetes models exclude women with diabetes at baseline.

IFG models exclude women with diabetes or IFG at baseline.

Metabolic syndrome models exclude women with diabetes or metabolic syndrome at baseline.